PATENT CLAIM ANALYSIS

Application Number: 15908024
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2018-11
Patent Classification: ["424", "158100"]

Abstract:
The invention relates generally to treatment of neurological disorders and nervous system injuries. The invention specifically provides methods of using modulators of particular target proteins to modulate degeneration of neurons or portions thereof, such as axons.

Claim (Index 7):
The method of  claim 4 , wherein said modulation of a target protein is an increase in the activity or expression of GSK3\u03b2, a decrease in the activity or expression of \u03b2-catenin, and/or a decrease in the activity or expression of TCF4.

Metadata:
- Claim Count in Document: 1.0
- Percentile: 88.0
- Lexical Diversity: 1.21875
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14822711', '13125333', '13722821', '14403523', '14087206']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7961743832366364
- 35 USC 102 Novelty (BERT): 0.582711387728413
- Combined Prediction Score: 0.774828083685814
- Mean Citation Score: 444.525628
- Max Citation Score: 674.8798
- Similarity Product: 377.2441014418245

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 0
- Label 101 Adjusted: 0

Dataset: test